Peptide Synthesis Webinar Series Introduces Second Installment: Synthesis of Difficult Peptide Sequences |
| Print | |
| Monday, 25 October 2010 15:30 (UTC + 2) |
|
Uppsala, Sweden, October 25, 2010 / b3c newswire / – Biotage (STO: BIOT), a leading supplier of tools and technology for medicinal and analytical chemistry, announced the second installment in its series of webinars focusing on peptide synthesis. The free events are in part a result of the research collaboration with Professor Knud J. Jensen at the Faculty of Life Sciences, University of Copenhagen, in developing new applications on the Biotage Syro Wave™ Parallel Peptide Synthesizer in the field of synthetic peptide and protein chemistry. The collaboration builds on Professor Jensen’s previous research in developing novel chemistries for applications of solid-phase peptide synthesis.
There is no charge for the webinar series which is available for viewing at www.biotage.com/peptides
Introduced today is the second installment in the webinar series: Robotic Peptide Synthesizer with Microwave Heating, Synthesis of Difficult Peptide Sequences. Presented at the 31st European Peptide Symposium, Copenhagen, Denmark 2010, by A. Pernille Tofteng, Faculty of Life Sciences, University of Copenhagen.
The popular first webinar in the series: Microwave & Parallel Peptide Synthesizer: The Best of Both Worlds was also presented at the 31st European Peptide Symposium in Copenhagen, by Amit Mehrotra - Product Manager, Synthesis and Marketing Manager, Peptide Chemistry.
The webinar series was announced following the recent introduction of Biotage Resolux™ HPLC columns for peptide purification. Resolux premiered at the ACS Fall 2010 National Meeting & Exposition in Boston, Massachusetts USA and at the 31st European Peptide Symposium in Copenhagen, Denmark.
For more information regarding Biotage, please email This e-mail address is being protected from spambots. You need JavaScript enabled to view it or visit www.biotage.com/peptides.
About Biotage - www.biotage.com
For further press information at Biotage please contact: USA |
